Psorcutan

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

48 API Suppliers, 20 USDMF, 11 CEP/COS, 1 EU WC, 1 KDMF, 15 NDC API, 21 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

68 Drugs in Development

68 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

113 FDF Dossiers, 23 FDA Orange Book, 55 Europe, 23 Canada, 7 South Africa, 5 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 0.005%, SOLUTION;TOPICAL - 0.005% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, OINTMENT;TOPICAL - 0.064%;0.005%, SUSPENSION;TOPICAL - 0.064%;0.005%, AEROSOL, FOAM;TOPICAL - 0.005%

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 DKSH, 4 Nanjing Well Pharmaceutical, 4 Kirsch Pharma, 3 Actylis, 12 BASF, 1 Corel Pharma Chem, 2 Finar, 1 Pluviaendo, 1 Seppic, 1 Symrise, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

20 Topical, 10 Parenteral, 7 Solubilizers, 5 Thickeners and Stabilizers, 4 Emulsifying Agents, 4 Film Formers & Plasticizers, 3 Lubricants & Glidants, 2 Direct Compression, 2 Granulation, 1 Surfactant & Foaming Agents, 1 Controlled & Modified Release, 1 Fillers, Diluents & Binders